Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment Regimens

By Rodi Maria   Dimisianos Nikolaos   de Lastic Anne-Lise   Sakellaraki Panagiota   Deraos George   Matsoukas John   Papathanasopoulos Panagiotis   Mouzaki Athanasia  

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-08 ,pp. : 1398-1398

MDPI

Access to resources Recommend Favorite

Gut–CNS-Axis as Possibility to Modulate Inflammatory Disease Activity—Implications for Multiple Sclerosis

By Fleck Ann-Katrin   Schuppan Detlef   Wiendl Heinz   Klotz Luisa  

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-07 ,pp. : 1526-1526

MDPI

Access to resources Recommend Favorite

Dendritic Cells and Multiple Sclerosis: Disease, Tolerance and Therapy

By Mohammad Mohammad G.   Hassanpour Masoud   Tsai Vicky W. W.   Li Hui   Ruitenberg Marc J.   Booth David R.   Serrats Jordi   Hart Prue H.   Symonds Geoffrey P.   Sawchenko Paul E.   Breit Samuel N.   Brown David A.  

International Journal of Molecular Sciences, Vol. 14, Iss. 1, 2012-12 ,pp. : 547-562

MDPI

Access to resources Recommend Favorite

Erythropoietin and Its Angiogenic Activity

By Kimáková Patrícia   Solár Peter   Solárová Zuzana   Komel Radovan   Debeljak Nataša  

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-07 ,pp. : 1519-1519

MDPI

Access to resources Recommend Favorite

The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets

By Mammana Santa   Fagone Paolo   Cavalli Eugenio   Basile Maria Sofia   Petralia Maria Cristina   Nicoletti Ferdinando   Bramanti Placido   Mazzon Emanuela  

International Journal of Molecular Sciences, Vol. 19, Iss. 3, 2018-03 ,pp. : 831-831

MDPI

Access to resources Recommend Favorite